AstraZeneca PLC
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 140.8B 134.0B 126.0B 138.1B
Cost of revenue 26.0B 22.9B 20.8B 25.3B
Gross profit 114.9B 111.1B 105.2B 112.8B
Operating expense
Research & development 34.0B 32.9B 29.3B 43.4B
Selling general and admin 48.5B 46.4B 42.9B 51.5B
Other operating expenses -825.2M -732.5M
Operating income 33.2B 32.5B 34.1B 18.9B
Non operating interest income
Income 788.1M 630.5M 778.8M 593.4M
Expense 4.0B 4.1B 3.2B 4.0B
Other income expense
Pretax income 30.1B 29.0B 31.5B 15.4B
Tax provision 6.6B 6.3B 4.5B 1.5B
Net income 23.5B 22.7B 27.1B 13.9B
Basic EPS 1.6 1.9 1.0
Diluted EPS 1.6 1.9 1.0
Basic average shares 14.4B 14.4B 14.4B
Diluted average shares 14.5B 14.5B 14.5B
EBITDA 48.5B 45.9B 46.7B 26.0B
Net income from continuing op. 30.1B 29.0B 31.5B 15.4B
Minority interests -18.5M 18.5M -46.4M 0
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 30 minutes

09:59
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CET, UTC+01:00).